Growth-arrest-specific 6 (GAS6) protein in ARDS patients: Determination of plasma levels and influence of PEEP setting

Respiratory Care

Volumn 58, Issue 11, 2013, Pages 1886-1891

  Diehl, Jean Luc ^a,b   Coolen, Nathalie ^a   Faisy, Christophe ^a   Osman, David ^c   Prat, Gwenaël ^d   Sebbane, Mustapha ^e   Nieszkowska, Ania ^f   Gervais, Claude ^g   Richard, Jean Christophe M ^h   Richecoeur, Jack ⁱ   Brochard, Laurent ^j   Mercat, Alain ^k   Guérot, Emmanuel ^a   Borgel, Delphine ^a,l  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSERM   (France)

^c BICÊTRE HOSPITAL   (France)

^d BREST UNIVERSITY HOSPITAL   (France)

^e HÔPITAL SAINT ELOI   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g DEPARTMENT OF NEUROLOGY   (France)

^h ROUEN UNIVERSITY HOSPITAL   (France)

ⁱ Hôpital Pontoise   (France)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^k ANGERS UNIVERSITY HOSPITAL   (France)

^l UNIVERSITÉ PARIS SACLAY   (France)

more..

Author keywords

ARDS; GAS6; Growth arrest specific protein 6; PEEP

Indexed keywords

BIOLOGICAL MARKER; GROWTH ARREST SPECIFIC PROTEIN 6; INTERLEUKIN 8; VASCULOTROPIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; ORGAN DYSFUNCTION AND INFECTION SCORE; POSITIVE END EXPIRATORY PRESSURE; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIMPLIFIED ACUTE PHYSIOLOGY SCORE;

ARDS; GAS6; GROWTH-ARREST-SPECIFIC PROTEIN 6; PEEP;

BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; POSITIVE-PRESSURE RESPIRATION; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; VENTILATORS, MECHANICAL;

EID: 84886260670     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02129     Document Type: Article

References (27)

1. Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (GAS6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993; 13(8):4976-85.
2. Hasanbasic I, Cuerquis J, Varnum B, Blostein MD. Intracellular signaling pathways involved in GAS6-Axl-mediated survival of endothelial cells. Am J Physiol Heart Circ Physiol 2004;287(3):H1207-H1213.
3. Borgel D, Clauser S, Bornstain C, Bièche I, Bissery A, Remones V, et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 2006;34(1):219-222.
4. Tjwa M, Bellido-Martin L, Lin Y, Plaisance S, Bono F, Delesque-Touchard N et al. GAS6 promotes inflammation by enhancing in-teractions between endothelial cells, platelets and leukocytes. Blood 2008;111(8):4096-4105.
5. Camenisch TD, Koller BH, Earp HS, Matsushima GK. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J Immunol 1999; 162(6):3498-3503.
6. Gibot S, Massin F, Cravoisy A, Dupays R, Barraud D, Nace L, et al. Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit Care 2007;11(1):R8. DOI: 10.1186/cc5158.
7. Ekman C, Linder A, Akesson P, Dahlbäck B. Plasma concentrations of GAS6 (growth arrest specific protein 6) and its soluble receptor sAxl in sepsis and systemic inflammatory responses syndromes. Crit Care 2010;14(4):R158 DOI: 10.1186/cc9233.
8. Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum BC, Henson PM, et al. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 2007;109(3):1026-1033.
9. Scutera S, Fraone T, Musso T, Cappello P, Rossi S, Pierobon D, et al. Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/GAS6 pathway. J Immunol 2009;183(5): 3004-3013.
10. Alciato F, Sainaghi PP, Sola D, Castello L, Avanzi GC. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J Leukoc Biol 2010;87(5):869-875.
11. Feng X, Deng T, Zhang Y, Su S, Wei C, Han D. Lipopolysaccharide inhibits macrophage phagocytosis of apoptotic neutrophils by regulating the production of tumour necrosis factor _ and growth arrestspecific gene 6. Immunology 2011;132(2):287-295.
12. Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, et al; Expiratory Pressure (ExPress) Study. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008;299(6): 646-655.
13. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999;282(1):54-61.
14. Bouros D, Alexandrakis MG, Antoniou KM, Agouridakis P, Pneumatikos I, Anevlavis S, et al. The clinical significance of serum and broncho-alveolar lavage inflammatory cytokines in patients at risk for acute respiratory distress syndrome. BMC Pulm Med 2004;4:6. DOI: 10.1186/1471-2466-4-6.
15. Parsons P, Eisner MD, Thompson BT, Matthay M, Ancukiewicz M, Bernard GR, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005;33(1):1-6.
16. Medford ARL, Ibrahim NBN, Millar AB. Vascular endothelial growth factor receptor and coreceptor expression in human acute respiratory distress syndrome. J Crit Care 2009;24(2):236-243.
17. Hildebrand F, Stuhrmann M, van Griensven M, Meier S, Hasenkamp S, Krettek C, et al. Association of IL-8-251A/T polymorphism with incidence of acute respiratory distress syndrome (ARDS) and IL-8 synthesis after multiple trauma. Cytokine 2007;37(3):192-199.
18. Lin WC, Lin CF, Chen CL, Chen CW, Lin YS. Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators. Exp Biol Med (Maywood) 2010;235(1):57-65.
19. Azamfirei L, Gurzu S, Solomon R, Copotoiu R, Jung I, Tilinca M, et al. Vascular endothelial growth factor: a possible mediator of endothelial activation in acute respiratory distress syndrome. Minerva Anestesiol 2010;76(8):609-616.
20. Ware LB, Koyama T, Billheimer D, Wu W, Bernard GR, Thompson T, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010; 137(2):288-296.
21. Agrawal A, Zhuo H, Brady S, Levitt J, Steingrub J, Siegel MD, et al. Pathogenic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two trials. Am J Physiol Lung Cell Mol Physiol 2012;303(8):L634-L639.
22. Wada T, Jesmin S, Gando S, Yanagida Y, Mizugaki A, Sultana SN, et al. The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) associated with critical illness. J Inflamm (London) 2013;10(1):6.
23. Clauser S, Peyrard S, Gaussem P, Crespin M, Emmerich J, Aiach M, et al. Development of a novel immunoassay for the assessment of plasma GAS6 concentrations and their variation with hormonal status. Clin Chem 2007;53(10):1808-1813.
24. Smadja DM, Borgel D, Diehl JL, Gaussem P. Vascular endothelial growth factor, as compared with placental growth factor, is increased in severe sepsis but not in organ failure. J Thromb Haemost 2012; 10(5):974-976.
25. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012; 38(10):1573-1582. Erratum in: Intensive Care Med 2012;38(10): 1731-1732.
26. Orfanos SE, Mavrommati I, Korovesi I, Roussos C. Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intens Care Med 2004;30(9):1702-1714.
27. Hurtado B, Garcia de Frutos P. GAS6 in systemic inflammatory diseases: with and without infection. Crit Care 2010;14(5):1003 DOI: 10.1186/cc9263.